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Abstract
There are hundreds of untested sexual assault kits in police custody. As of 2017, New
York State passed a law stating that all untested kits must be turned over to forensic laboratories
to be tested, causing backlogs at laboratories to increase. The Y-Screen assay is a DNA
extraction protocol which utilizes NaOH to rapidly lyse epithelial and sperm cells, and the
Quantifiler Trio DNA quantification kit to detect the presence or absence of male DNA prior to
standard sample processing. The Y-Screen assay is a commercial product used in this research
to test a defined set of validation samples with or without a male contributor. Here we found that
there is a correlation between the results of the Y-Screen assay and the results of the standard
extraction and DNA typing. For most samples that tested positive with the Y-Screen assay, male
DNA profile results were detected after amplification and electrophoresis of the same sample. If
the Y-Screen results were extremely low (below 0.0007ng/μl) then, it is likely that the
downstream DNA profile will not yield male DNA either. But there were exceptions. After
implementation of the Y-Screen assay a total of 669 casework swabs were tested and from that
number 352 (approximately 53%) swabs tested positive for the presence of male DNA without
undergoing serology testing. The types of swabs testing positive were vaginal, vulvar, anal,
perianal, and dried secretion swabs. The swabs that usually tested negative were the oral swabs.
In conclusion the Y-Screen assay effectively streamlines the processing of sexual assault kits
(SAK) samples.
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Introduction
Sexual Assault Kits
Sexual violence is a pervasive social problem; national epidemiological data indicate that
18%-25% of women are sexually assaulted in their adult lifetimes (Black et al., 2011). The
victims are advised to have a medical forensic exam, which includes caring for injuries sustained
in the assault, emergency contraception if applicable, administering prophylaxis for sexually
transmitted infections that could have been contracted, and the collection of a sexual assault kit
(SAK)(Campbell & Fehler, 2015). A SAK is a standard kit that is comprised of multiple
envelopes containing swabs, slides, and other trace evidence collected from the victim. There can
be a total of 10 different sets of swabs collected from different areas of the victim, as well as five
slides and then underwear and trace evidence. Examples of some items collected in a kit are head
hair, pubic hair, swabbing of the vagina, anus, mouth, and/or breast for the collection of semen
(Campbell & Fehler, 2015). The SAK has instructional forms on how each item should be
collected and packaged in order to prevent contamination and degradation of the sample. The
items that can be found in one of these standardized kits are as follows: oral swab and smear,
exemplar, trace evidence, underwear, debris, dried secretion swabs, fingernail scrapings, pulled
head hair, pubic hair combing, pulled pubic hair, perianal and anal swabs and smear, vaginal
swabs and smear, and cervical swabs and smear (“SWGDAM”, 2016). The collection process for
SAKs is time-consuming and highly invasive for the victim. After the SAK has been collected by
a SANE (Sexual Assault Nurse Examiner) nurse, it is taken into custody by law enforcement
personnel, who then become responsible for submitting it to a forensic laboratory for testing
(Campbell & Fehler, 2015). At the laboratory the kits are screened for biological evidence, and
analyzed for DNA. The resulting DNA profiles are uploaded to the Combined DNA Index
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System (CODIS), the national forensic DNA database consisting of DNA profiles from
arrestees/convicted offenders and crime samples. The samples are compared to those references
and, if there is a match (hit), it provides investigators with a lead (Campbell & Fehler, 2015).
Sexual assault evidence is collected focusing on alleged actions during the assault.
Studies have shown that evidence collection for each body fluid has a time frame for post-coital
DNA persistence time. Semen has the longest period of time for being present on the surface of
the body, and within the body after a sexual assault (National Institute of Justice, n.d.). The goal
of processing SAK’s is to obtain a CODIS eligible profile. The factor that determines CODIS
eligibility is: if it is a sample collected from a crime, and if it is does not match the victim’s
exemplar, and if it is believed to be from the perpetrator (“SWGDAM”, 2016). High throughput
is a standard approach done with consistent sample types and a defined workflow using
automated technology and robotic instrumentation to produce uniform reported results
(“SWGDAM”, 2016).
SAKs account for a significant portion of the cases received in most labs. Processing
SAK evidence is time consuming, labor intensive, and expensive because each item is tested
separately. The first test done with the swabs from SAK’s is a serological test for the presence of
semen.
Acid Phosphatase and PSA Testing
It can take 4-6 hours to screen SAK evidence (Holt A.,Marfori M., Olson,S., &Yong
Ning Oh, D., 2015). The screening of a sexual assault kits begins with an inventory and
itemization of all the items collected in the kit. All the slides get submitted for staining and
microscopic examination for sperm cells. The time frame of 4-6 hours does not include the
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reading or running of any samples. This can include serological testing such as Acid Phosphatase
(AP) and Protein Specific Antigen (PSA) detection. If sperm is detected, the sample is processed
using differential extraction. After the serology testing is complete, the slides associated with
those samples are stained and read.
A limitation of using AP and PSA serology testing to triage samples that will get pushed
downstream for DNA extraction, is the fact not all SAK scenarios are the same. The serological
AP and PSA tests screen the samples for the presence of a semen protein. For example, if the
victim reports that the perpetrator ejaculated on her, there is a good chance that the protein
screening will detect the semen on the samples. But say the victim stated that the perpetrator
forcibly penetrated her but there was no ejaculation. With only a semen test being used to triage
which samples get extracted, those samples that have the perpetrators saliva or epithelial cells
will be missed. Another limitation with AP and PSA serology testing is that it can be time
consuming and expensive. It is expensive to run each swab on its own P30 card. A single P30 kit
can process only 25 samples. A SAK can have up to 10 swabs in a single kit, which means one
P30 kit can only test at most 2 and a half SAKs. This current method of triaging samples is also
considered to be time consuming, since most forensic laboratories batch samples. Once the
samples have been tested with AP and PSA, if the results aren’t concordant, the original slide
and an extract slide would need to be examined. It can take up to four weeks to have a sample be
put in for DNA extraction.
Backlog
The problem is that there are an increasing number of untested kits in police custody that
will be turned over to forensic laboratories for testing. With the increased numbers of SAK’s
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being submitted to labs, the lack of resources to test the kits is causing a backlog. The term
“backlog” is often used by jurisdictions that have identified “un-submitted” (not unreported)
SAKs during their audit or inventory in a forensic laboratory. The definition of backlog is as
follows: a case(s) received by the laboratory that exceeds the laboratory’s capacity and is (are)
awaiting testing (“SWGDAM”, 2016).
In a National Institute of Justice (NIJ) funded survey of 1,692 law enforcement agencies,
it was estimated that there were 169,000 rape cases dating back to 1982 that contained untested
biological evidence (Campbell & Fehler, 2015). A more recent study conducted by Strom and
Hickman in 2010, surveyed 2,250 law enforcement agencies and estimated that 10% (27,595) of
all unsolved sexual assault cases since 2003 contained un-submitted forensic evidence (Strom
&Hickman, 2010). In a study done by Campbell and Fehler it was found that 41% of SAKs were
not submitted for analysis, and a similar percentage of kits collected from minors were also not
submitted (Campbell & Fehler, 2015). This leads to the question why are some kits submitted
and others not; and, are there certain criteria that must be met?
Strom and Hickman, conducted a study in 2010 that looks into why some SAKs are
submitted and others not. In their study, they determined that 44% of the respondents did not
submit evidence if a suspect had not been identified; 24% if the suspect had already been
adjudicated; 19% if the case had been dismissed; 17% if they did not think it was useful; 15% if
testing was not requested; and, 12% if the suspect had been identified but not charged (Strom &
Hickman, 2010). Another reason as to why police agencies would not submit the SAKs for
analysis was based on the victim reporting bathing post-assault, and the belief that the evidence
would be compromised (Campbell & Fehler, 2015). A study by Campbell also determined that
victims between the ages of 13 to 15 were more likely to have their kit submitted than victims
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aged 16 to 17 years old, because the agencies find children more credible than adolescents
(Campbell & Fehler, 2015). For adult victims it was found that cases in which the victim was
injured, the perpetrator used force, and the assault involved penetration the SAKs were
submitted. This suggested that if the police did not submit the evidence it was because they
doubted the evidentiary value of the kits and/or doubted the credibility of the victim (Campbell
& Fehler, 2015).
In recent years the problem of high SAKs backlog has come to light. 2016 has been a
year of addressing the issue with new laws being put in place and depicting criteria on how to
handle sexual assault kits delineated. One problem affecting the backlog is the fact that police
agencies, and hospitals, have many untested SAKs in their possession. They then transferred all
those untested kits to the custody of forensic laboratories.
This issue of untested SAKs is not only relevant in New York, but all over the United
States. Another place were the SAK backlog is extremely high is Detroit, Michigan. Detroit has
one of the largest backlogs of untested SAKs in the United States. In order to combat this
problem the Detroit Sexual Assault Kit (SAK) Action Research Project (ARP) was created
(Campbell & Fehler, 2015). The Detroit lab proved to have a backlog issue of SAKs. In 2008;
after a census was conducted the lab had a total of 11,219 SAKs spanning from 1980 to 2009
that were untested (Campbell & Fehler, 2015). According to an article in Forensic Magazine,
Alaska is also dealing with this backlog issue. Alaska State Troopers have more than 1,000
untested kits containing DNA evidence from sexual assaults. In 2016, the Juneau Police
Department had about 350 untested kits and the Anchorage Police Department had another
1,400. Unlike most states Alaska received $1.1 million last Fall to test the kits, but that hasn’t
happened yet. A statewide group, known as the Sexual Assault Kit Initiative working group is
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developing a testing priority to make sure the money is used as efficiently as possible
(Associated Press, 2017). According to another article in Forensic Magazine, Virginia has had
44 “Hits” on the old testing of backlogged rape evidence. The article states that “DNA testing in
431 cases of collected, but previously untested biological evidence recovered in Virginia rape
cases, has resulted in 44 DNA database “hits” (Green, 2017, pg.1), which shows the value of
processing backlog kits. In 2015, a statewide inventory of law enforcement agencies by the
Virginia Department of Forensic Science found that there were nearly 3,000 untested “PERKs”
(physical evidence recovery kits)for crimes that occurred from 1985 to June 30, 2014 (Green,
2017).
The NIJ (National Institute of Justice) has convened a multidisciplinary team called the
Sexual Assault Forensic Evidence Reporting (SAFER) Act working group SART (Sexual
Assault Response Team) (National Institute of Justice, n.d.). The SAFER group has suggested to
eliminate the smear slides from the collection kit. The slides have been shown to take up time
and have been deemed as unnecessary because they contain epithelial cells, bacteria and other
debris that do not help in subject identification (National Institute of Justice, n.d.). YSTR testing
analyzes the STRs (Short Tandem Repeats) on the Y-chromosome. YSTR can be combined with
autosomal STRs for additional information that can be used to determine the perpetrator. The
SAFER group has a few recommendations they feel if followed, will help streamline the analysis
process of SAKs. One of the recommendations is that examiners should concentrate the
collection of evidentiary samples to no more than two swabs per collection area as to not dilute
the sample (National Institute of Justice, n.d.).
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Rape Kit Law
To prevent backlogs in the future a new law was passed in 2017. The law states that
every untested kit must be submitted to a laboratory for testing, and has placed some criteria for
new kits that are collected (New York State, 2016). Some of the criteria are as follows; each
forensic laboratory receiving sexual offense evidence kits after the effective date shall develop
Combined DNA Index System (CODIS) eligible profiles from potential perpetrators from the
evidence tested within 90 days of receipt, each laboratory within one hundred and twenty days
after receiving kit shall develop a CODIS eligible profile from old kits (New York State, 2016).
The rape kit backlog law was created by subdivision 838-a of the executive law, as
proposed by A.10067-A and S.8117 (“SWGDAM”, 2016). The bill is identified as S8117 bill.
The law was signed into Congress in November of 2016, but was not put into effect until
February 26 2017. The law has several different components. The first component is that each
police agency and prosecutorial agency must submit any sexual assault kits to a forensic
laboratory within 10 days of receipt of kit into their custody (New York State, 2016). The next
component is that each forensic laboratory then assesses the case specific information for CODIS
eligibility and develop profiles. The labs have 90 days from receipt of kit to accomplish this.
Another component of the law deals with the backlog and the kits currently in police custody.
Police agencies have 90 days since this law was put into effect to turn over all kits to forensic
laboratories. The labs have 120 days upon receipt to generate CODIS eligible profiles and
inventory the kits. The law even details the reporting requirements for the labs and investigating
agencies (New York State, 2016). This law caused a push for streamlining SAK processing
procedures of SAKs.
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Extraction
There are two different types of extractions used in this validation. Both of the extraction
methods are performed using robotic instrumentation such as the QiaSymphony from Qiagen and
the Automate from Applied Biosystems (ABI). The first type of extraction is the differential
extraction, which is used on samples that are positive for male semen. It lyses the DNA from the
substrate, in this case swabs, and separates the DNA into two fractions, the epithelial fraction
(EF) and the sperm fraction (SF) (Butler, 2005). For this validation the SF is the relevant
fraction because it is where the male DNA is expected to be. The SF fraction can be tested for
autosomal or Y-chromosome specific Short Tandem Repeats (STRs). The second type of
extraction is the standard robotic extraction for non-semen evidence, meaning this would be done
on samples that had saliva or touch male DNA. This extraction lyses the DNA from the swab and
purifies it (Westchester County Forensic Laboratory, 2017). The extracts are then quantified
using the Quantifiler Trio quantification kit. Once the concentration of the sample is determined
they are amplified and STR typed.
YSTRs
The Y-chromosome is approximately 60Mb in length. The breakdown of the 60Mb
lengths is a transcribed region 35Mb in length, while the remaining 25Mb length corresponds to
the non-transcribed region. What makes the Y-chromosome unique is the fact that it is rich in
many different kinds of repetitive sequences. The Y-chromosome is characterized by 200 SNPS
and a 10-3 hotspot on the chromosome that is known for mutations to occur. The YSTR approach
targets male DNA and is advantageous in cases with female victims and a male perpetrator.
Since the vast majority of sexual assaults involve male perpetrators, Y-chromosome specific
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DNA testing is designed to only look at the male portion of mixtures, in which autosomal testing
revealed high levels of female DNA (Butler, 2005). The use of Y chromosome specific PCR
primers improves the chances of detecting low levels of the perpetrator’s DNA in high
background of the victim’s DNA (Butler, 2005).
YSTRs are mainly used when evidence is positive for semen but no DNA foreign to the
victim can be detected, when the evidence in question is amylase positive and a male/female
mixture is expected, when a large number of semen stains need to be screened and when the
number of semen donors needs to be determined (Butler, 2005). The ability to identify malespecific DNA and highly variable Y-chromosomal polymorphisms, is an invaluable addition to
the standard panel of autosomal loci used in forensic genetics (Roewer, 2009). The use of YSTR markers also extends the post-coital interval for successful male DNA detection
(Ballantyne, 2012).
Y-Screen
The Y-Screen test is a quick assay to be run on swabs collected from sexual assault kits
to assess whether male DNA is present on the swab to then proceed with either differential
extraction, or standard robotic extraction. A previous study conducted by Applied Biosystems,
created the Y-Screen assay to help labs deal with untested SAKs in a more efficient way
(Thermo Fisher Scientific, 2015). It utilizes sodium hydroxide (NaOH) to lyse the cells and
Quantifiler trio (ABI) to detect the absence or presence of male DNA prior to processing the kit.
The Quantifiler Trio Kit is a Real Time Polymerase Chain Reaction (RT-PCR) kit that
determines how much DNA is in the sample. There are four targets: two autosomal human
specific (80 bp and 214 bp) DNA sequences, one male target with 75bp, and the IPC (internal
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positive control) with 120bp (Holt & Marfori et.al. 2015). In a DNA screening assay study
conducted by Holt, the results showed that male DNA profiles could be developed using this
approach. The study used one autosomal STR kit (ID+, Identifier Plus), and one Y-chromosome
specific STR kit (YF, Y-Filer) kits to obtain their results (Holt & Marfori et.al., 2015). This
study concluded that there is a correlation between pre-extraction quantification results and
downstream STR results.
Screening for male DNA using quantification and YSTRs is significantly more sensitive
than the regular serology screening (“SWGDAM”, 2016).The technique used is a quick nondifferential extraction of ⅛ of the swab to determine, if male DNA is present. If no male DNA is
detected, then no further processing of the sample is needed (“SWGDAM”, 2016). The Y-Screen
assay is a useful DNA confirmatory screening tool when used with other presumptive screening
methods. The manufacturer’s validation claims that the sensitivity of the assay correlates well to
the results obtained from differential extraction procedures, using a range of differential
extraction procedures. The assay also provides a better correlation to resulting STR profiles
when compared with commonly used serology methods. In addition the assay has shown to be
more sensitive than the current serology tests. By confirming conclusive and inconclusive
serology results, the assay is able to add assurance about the type of sample quantity. The YScreen assay promises to solve important sample screening and processing problems, allowing
forensic laboratories to more rapidly process SAK samples (Holt & Marfori, et.al, 2015).
Eliminating the rape kit backlog requires a new processing procedure to keep up with the
high throughput of some labs. The Y-Screen assay can be used as a tool to triage sexual assault
kits by confirming whether or not swabs contain a male contributor. Filtering negative kits from
downstream DNA analysis can save time, money and effort. Here, we perform a validation study
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using a set of mock casework samples and control samples. A portion of each swab will be cut
for Y-Screen; a second cutting will be used for a standard DNA extraction, and quantitation and
short tandem repeat (STR) analysis according to standard operating procedures (SOP). The YScreen assay is only to be used for swab samples. Fabric samples may contain Polymerase chain
reaction (PCR) inhibitors and since this is a crude lysis procedure, PCR inhibitors will not be
removed by this assay. The FBI Quality Assurance Standard (QAS) were used to determine
which studies to conduct at the Westchester County Forensic Laboratory for the internal
validation of the Y-Screen assay (FBI, 2011). Based on the FBI and the ANAB standards for
accreditation, the studies that must be conducted in an internal validation are as follows: a known
and non-probative samples study, reproducibility and precision, sensitivity study, mixture study,
and a contamination study.
Methods and Materials
The Y-Screen assay from Applied Biosystems was only validated for sexual assault kit
swabs. This assay is not suitable for fabric samples that may contain PCR inhibitors.
(ThermoFisher Scientific,2015). This assay is a two- step procedure which uses a crude
extraction procedure followed by running the extract with the Quantifiler Trio kit to assess
whether male DNA is present.
Known/Mock Evidence Samples
Known and mock casework samples were created to mimic positive and negative rape kit
swabs (male DNA present or not present). Table 4 lists the known/ mock evidence samples that
contained semen; this includes several post coital samples from volunteer donors. Table 5 lists
the known/ mock evidence samples that did not contain semen. These samples were designed to

12
mimic dried secretion swabs which are found in rape kits. They consisted of mixtures of female
body swabs with either male saliva or other male DNA.
Sensitivity/Mixture samples
Two sets of mixture swabs were prepared for this study. The first set consisted of female
buccal swabs with male saliva dilutions. The male saliva dilutions were made as follows: 1:2,
1:10, 1:100, 1:1k, 1:5k, 1:10k, 1:15k, 1:20k, 1:50k. The second set of swabs consisted of female
buccal swabs and semen dilutions. The dilutions of semen were made as follows: 1:2, 1:10,
1:100, 1:1k, 1:5k, 1:10k, 1:15k, 1:20k, 1:50k, 1:100k. Fifty microliters of each dilution was then
added to the female buccal swabs, keeping the female component constant. The dilutions were
made with the same female and male contributors.
Reproducibility/Repeatability samples
These were four mixture swabs of 1:1 mixtures of semen: saliva that were cut in triplicate
and pooled to demonstrate the reproducibility of the assay. Two analysts were assigned the same
four swabs. The goal was to extract the DNA from the pooled swabs and correctly identify, if
there was male DNA present or not.
Contamination samples
For the contamination study blank swabs were cut into the tubes and extracted alongside
the samples to ensure there was no contamination in the reagents being used or caused by the
extraction method for the assay (see table 11).
Y-Screen Assay
The first step in the Y-Screen assay is to cut 1/8 piece of the cotton swab, saving a
portion for differential/standard extraction. The cutting is placed in a LySep column/tube (ABI)
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with 100 microliters of 1N NaOH and incubated for 10 minutes at 80°C at 750rpm. The LySep
column is then centrifuged for 2 minutes at 12,000rpm and discarded. 4 microliters of glacial
acetic acid is then added and the sample is diluted 1:5 in low TE (10mM Tris-HCL,0.1mM
EDTA. 400 microliters of low TE are added.
DNA Extraction, Quantitation and STR Typing
All of these procedures were conducted using the Westchester County Forensic
Laboratory’s current SOP: Extraction for non-semen samples was performed on the Automate
Extraction Robot with the Prepfiler Kit (Westchester County Forensic Laboratory “Extraction
Manual”, 2017). Differential extraction for semen samples initially followed several manual
extraction steps to separate the two fractions. The two fractions are then placed on the Automate
Express using the Prepfiler kit to purify the DNA. Quantitation was performed with the
Quantifiler Trio kit and 7500 Real-Time PCR system with HID Real-Time Analysis Software
v1.2 (all from Thermo Fisher Scientific Lifetechnologies). For human STR amplification and
electrophoresis the study used GlobalFiler™ and Yfiler® for 29 cycles on GeneAmp 9700
Thermal Cyclers. 3500 &3130 Genetic Analyzers were used for electrophoresis with data
collection software v2.0 and GeneMapper ID-X Software v1.4 for data analysis (all from
Thermo Fisher Scientific Lifetechnologies). Analysis thresholds and stutter filters were kept
based on the Westchester County Forensic Laboratory’s current SOP. For autosomal STR testing
the following results are possible: mixture of male and female DNA (the male may be partial);
single source (SS) female or male DNA; no amplification. For Y-STR testing the following
results are possible: full Y-STR profile with all expected alleles detected, partial Y-STR profile,
and no profile.
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Results
We found that there is a correlation between the results of the Y-Screen assay and the
results of the secondary standard extraction and STR DNA typing. For most samples that tested
positive with the Y-Screen assay, male DNA profile results were detected after the standard
extraction, amplification and capillary electrophoresis (CE) of the same sample. If the Y-Screen
results were extremely low (around or below 0.0006ng/µl) then, it is likely that the downstream
DNA profile will not yield male DNA. For those samples testing negative for the Y-Screen
assay, no male interpretable STR DNA profiles were generated.
This Y-Screen assay was able to detect male DNA in samples that were negative with our
conventional AP and PSA screening tests. Male DNA detection proved to be reproducible among
different cuttings of the same sample and different analysts sampling the same sample. It proved
to be sensitive with dilutions of male semen and saliva, and detected male DNA on post coital
swabs. See below for a detailed description of the results.
Sensitivity
Table 1 lists the results for the sperm fractions of the mixed buccal: semen swabs. Male
DNA was detected down to the 1:100K dilutions in both the Y-Screen assay and the standard
extraction/quant method. A Y-STR profile was obtained down to a dilution of 1:1K. Samples
with dilutions greater than 1:1K generated no male DNA profiles with GlobalFiler™ or Yfiler®.
Based on the quantitation values for those samples, we would not expect a male profile to be
detected since the values are below our amplification threshold set by the laboratory for both
kits. Samples with a Y-Screen male target value below 0.0007ng/ μL did not result in STR types
after extraction. These samples can be considered false positives, since male DNA is being
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detected but no STR profile is being generated. However, the samples are from different and
larger cuttings, female DNA interferes with GlobalFiler typing, and the amount of male DNA
was very low. This data set shows that Y-Screen results below 10pg/μL are predictive of a lack
of success for STR typing.
Table 1. Sensitivity for semen

Sample Type
buccal:semen neat

Yscreen Y-Screen
Regular
Regular Regular
Human
Male Y-screen
Ext.
Ext. Male Ext.M:F
Fraction
Target
Target M:F Ratio
Human
Quant
Ratio
Quantity Quant
Quant
1:1.07 not tested
4.6020 4.9388

GlobalFiler Results

Y-Filer
Results

1:1.28 not tested

buccal:semen(1:2)

2.3160

2.9659

buccal:semen(1:10)

0.6792

0.2217

1:2.1

SF

0.2021

0.3295

1:1.6

Mixture

Full Y-STR

buccal:semen (1:100)

0.4138

0.0469

1:7.8

SF

0.0160

0.0215

1:1.3

Mixture

Full Y-STR

buccal:semen(1:1k)

0.2867

0.0038

1:75

SF

0.0050

0.0020

1:1.4

buccal:semen(1:5k)

0.2239

0.0006

1:357

SF

0.0073

0.0001

buccal:semen(1:10k)

0.5303

0.0003

1:1842

SF

0.0024

0.0003

buccal:semen(1:20k)

0.0814

0.0000

n/a

SF

0.0004

0.0002

buccal:semen1:50k)

0.1564

0.0000

n/a

SF

0.0049

0.0003

buccal:semen(1:100k)

0.0498

0.0001

1:357

SF

0.0010

0.0002

y-screen extract
Secondary extraction

Mixture
Mixture - 2 low level
1:83
male alleles
Partial female - 1 male
1:7.5
peak called
Partial female - 3 low
1:2
level peaks (no male
called)
Partial female - 1
1:16
male peak
Partial female - 3 low
1:3
level peaks (no male
called)

Full Y-STR
No Profile
No Profile
No Profile
No Profile
No Profile

DNA quantitation values are in ng/μL the term “regular” refers to the quantitation value
obtained for the sample after a differential extraction (secondary extraction) occurred.

There were a total of twelve samples that were tested using AP/PSA and the differential
extraction method (see table 2). For the eight positive Y-Screen samples male DNA profiles
were generated for GlobalFilerTM and YFiler®. The AP/PSA positive samples all yielded male
DNA. Of the eight samples that tested AP and PSA negative there were mixed results. In three of
the samples that were AP/PSA positive, male DNA profiles were detected using YSTR’s. Two
samples detected low level male alleles and the other three samples did not detect male DNA
profiles. The five samples in the chart that did not generate male DNA profiles all had very low
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Y-Screen male target quant values (lower than 0.0007 ng/μL) or were negative with the male
quant. The results of these samples demonstrate that the Y-Screen method is more sensitive than
the conventional AP/PSA screening test. Even if the AP and PSA results are negative, the YScreen assay is sensitive enough to detect male DNA, because the DNA target is amplified with
the polymerase chain reaction. It will be an effective way of screening sexual assault kit swabs
that may or may not have semen present on them.
Table 2. AP/PSA results
(This table contains only SF results)
Sample Type

AP

PSA

Blood:semen
peri anal:semen
(fecal material)
48 Hr PC*

3

Positive

Yscreen
Human
Target
Quantity
1.1726

Y-Screen
Male
Target
Quant
1.4794

3

Positive

0.3722

0.4598

0

Negative

6.0153

72 Hr PC*

0

Negative

GlobalFiler
Results SF

Y-Filer SF

Mixture

Full Y-STR

SS Male

Full Y-STR

0.0019

Mixture

3 Loci

3.8376

0.0127

Mixture

Full Y-STR

buccal:semen(1:10)

1

Positive

0.6792

0.2217

Mixture

Full Y-STR

buccal:semen (1:100)

0

Weak Pos

0.4138

0.0469

Mixture

Full Y-STR

buccal:semen(1:1k)

0

Negative

0.2867

0.0038

buccal:semen(1:5k)

0

Negative

0.2239

0.0006

buccal:semen(1:10k)

0

Negative

0.5303

0.0003

buccal:semen(1:20k)

0

Negative

0.0814

0.0000

buccal:semen(1:50k)

0

Negative

0.1564

0.0000

buccal:semen(1:100k)

0

Negative

0.0498

0.0001

Mixture
Full Y-STR
Mixture (low
level male) No Profile
SS Female

No Profile

SS Female
No Profile
Female profile
w/ 1 male
peak
No Profile
SS Female

No Profile

DNA quantitation values are in ng/μL. * The 48 hour Post Coital and 72 hour swabs were from different sample
sets.. These swabs were used from prepared material from the 2012 “Post Coital Time Interval Study”.

Table 3 lists the results for the mixed buccal: saliva swabs. The Y-Screen assay was able
to detect male saliva DNA down to 1:100 dilution. The 1:100 sample gave a partial male Y-STR
profile. The standard extraction method gave male quantitation values down to 1:50K, but these
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swab samples yielded no male STR DNA profiles. From this dilution series of nine samples,
five were Y-Screen positive, and four of the five generated Y-STR profiles. The 1:20K dilution
gave a weak positive result with the Y-Screen assay and the standard extraction but no male
DNA profile was generated with the GlobalFiler TM or Yfiler® kit. Here a low Y-Screen value
of 0.0006 ng/µL still gave a partial Y-STR profile. As expected based on autosomal STR mixture
ratio detection levels (Butler 2005), a male Globalfiler component was only seen for the neat, 1:2
and 1:10 samples.
Table 3. Sensitivity for Male Saliva

Sample Type
buccal:saliva neat

Yscreen Y-Screen
Human
Male Y-screen
Target
Target M:F Ratio
Quantity Quant
0.7155 0.2608
1:1.7

Regular
Regular Regular
GlobalFiler Y-Filer
Ext.
Ext. Male Ext.M:F
Results
Results
Human
Quant
Ratio
Quant
1.1100 0.2299 1:3.8
Mixture
Full Y-STR

buccal:saliva (1:2)

0.3514

0.1156

1:2

2.1199

0.1034

1:20

Mixture

Full Y-STR

buccal:saliva (1:10)

0.5815

0.0123

1:46

3.9049

0.0739

1:52

Mixture

Full Y-STR

buccal:saliva (1:100)

0.5061

0.0006

1:903

2.3208

0.0046

1:508

SS Female

10 loci

buccal:saliva(1:1k)

0.1419

0.0000

n/a

0.7976

0.0010

1:831

SS Female

No profile

buccal:saliva(1:5k)

0.6368

0.0000

n/a

3.6653

0.0001

1:35065 SS Female

No profile

buccal:saliva(1:10k)

0.3842

0.0000

n/a

6.8773

0.0006

1:10644 SS Female

No profile

buccal:saliva(1:20k)

0.2712

0.0002

1:1482

1.1957

0.0001

1:13411 SS Female

No profile

buccal:saliva(1:50k)

0.2429

0.0000

n/a

1.9378

0.0005

1:3574

No profile

y-screen extract
Secondary extraction

SS Female

DNA quantitation values are in ng/μL. The dilution swabs are all made the same way,
using the same contributors.

Known/Mock Samples
Table 4 lists mock casework samples that contain semen. All samples were extracted
with the Y-Screen assay procedure and quantified using the Quantifiler Trio kit. A second
cutting was taken and the samples were extracted with a differential extraction, quantified and
carried through to CE using both the GlobalFiler™ kit and the Yfiler® kit.
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Table 4. Known/Non-Probative sample with semen
Y-Screen Y-Screen
Human
Male
Target
Target Y-Screen Fraction
Quantity Quant M:F Ratio

48 Hr PC

6.0153

0.0019

1:3198

SF

Regular
Ext.
Human
Quant
0.0623

72 Hr PC
Blood:semen
(50ul each)

3.8376

0.0127

1:301

SF

1.1726

1.4794

1.3:1

peri anal:semen
0.3722
(fecal material)

0.4598

Sample Type

Regular Regular
Ext. Male Ext.M:F GlobalFiler Results
Quant
Ratio

Y-Filer
Results

0.0010

1:63

Mixture

3 loci

0.0196

0.0078

1:1.5

Mixture

Full YSTR

SF

0.9967

1.2109

1.2:1

SS male

Full YSTR

1.2:1

SF

9.792

4.784

1:2.0

SS male

Full YSTR

4 Days PC

12.3990

0.0004

1:28629

SF

0.0555

0.0022

1:24

SS female

No profile

5 Days PC

7.8373

0.0000

n/a

SF

0.0353

0.0001

1:240

SS female

No profile

y-screen extract
Secondary extraction

DNA quantitation values are in ng/μL Note: 48 Hr PC & 72 Hr PC swabs were from
different sample sets. PC= post coital.

All of the samples that gave a positive result with the Y-Screen assay and the differential
extraction procedure yielded profiles that contained male DNA ranging from full single source
profiles, to mixtures, and full or partial Y-STR profiles. The DNA profiles detected with both
the GlobalFiler™ and Yfiler® kits were concordant with the known contributors to the samples.
This was true for both the SF and EF fractions of these mixtures (only the results of the semen
fractions are listed in table). Please note that the peri anal sample did not have a female profile
even though the swab was taken from a female donor. It should be noted that the purpose of this
swab was to show that the Y-Screen assay would not be inhibited by the presence of fecal matter.
Table 5 lists mock casework samples that contained male DNA from sources other than
semen. Again, each swab was subjected to the Y-Screen assay and then quantified. A second
cutting was taken and the swab was extracted on the Automate, quantified and carried through to
CE. All of the swabs that tested positive with the Y-Screen assay generated some type of male
DNA profile after the standard extraction was performed and analyzed with the GlobalFiler™
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and Yfiler® kits. Some samples generated male DNA profiles in GlobalFiler™ and Yfiler®,
while others generated a male DNA profile only in Yfiler®. The profiles generated in both the
GlobalFiler™ and Yfiler® results were concordant with the known contributors to the samples.
Table 5. Known/Non-Probative non-semen

1:48

Regular
Ext.
Human
Quant
8.3812

0.224

1:36

SS Female

Full YSTR

Vulvar(Digital penetration)
Vulvar swab (penetration no semen)
Dried Secretion (f:m)

5.7122

0.0065

1:873

39.9436

0.0681

1:585

SS Female

15 loci

3.2642

0.0010

1:3256.6

16.125

0.01

1:1615

SS Female

12 loci

0.0002

0.0001

1:2

0.07

0.0527

1:1.3

Mixture

Full YSTR

(Bite mark) (f:m)

0.0060

0.0068

1.3:1

0.2138

0.2239

1:1

Full YSTR

Dried Secretion(Neck) (f:m)

0.0297

0.0195

1:1.5

0.5071

0.4965

1:1

Arm swabbing (grabbed by
male)

0.0044

0.0036

1:1.2

0.0773

0.0973

1.3:1

No profile

Sample Type
Vulvar (oral contact)

Y-Screen
Human
Target
Quantity
3.2074

Y-Screen
Male
Target
Quant
0.0673

Y-Screen
M:F Ratio

Regular
Ext. Male
Quant

Regular
Ext.M:F
Ratio

GlobalFiler
Results

Y-Filer
Results

Oral (no male)

0.0269

0.0000

n/a

1.7605

0

n/a

SS Male
Mixture
male is
major
Mixture male is
major
SS Female

Dried secretions (no male)

0.0243

0.0000

n/a

0.0886

0.0001

1:947

SS Female

No profile

Peri anal (no male)

0.0974

0.0000

n/a

0.0061

0

n/a

SS Female

No profile

Vulvar (no male)

0.0162

0.0000

n/a

0.0792

0

n/a

SS Female

No profile

vaginal (no male)

0.0232

0.0000

n/a

0.0347

0.0003

1:134

SS Female

No profile

y-screen extract
Secondary extraction

Full YSTR

Full YSTR

DNA quantitation values are in ng/μL

The samples of table 5 which are known to contain male DNA but not from semen are
typically not flagged for DNA testing by our traditional serological screening methods, since the
traditional screening is testing for components of semen (AP, PSA and microscopic screening for
sperm cells). We occasionally screen for saliva but only when requested, or if the case scenario
suggests that it may be present. So these STR profiles may have been missed. In addition, five
mock samples from a female were collected that did not have male DNA present. All of these
samples tested negative with the Y-Screen assay, and after the standard DNA analysis procedure
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was performed, no male DNA profiles were detected with either the GlobalFiler™ or the Yfiler®
kits. Two of the samples (dried secretions and vaginal swabs) had been negative with the YScreen assay, but then gave low male Quantifiler Trio target values after standard extraction. The
values for these two samples were below our STR amplification threshold (Westchester County
Forensic Laboratory “Y-Screen”, 2017).
Mixtures
Table 6 combines previously listed samples, this time sorted by the male to female
mixture ratio after standard or differential extraction. It is expected that with an increasing
amount of female DNA male DNA cannot be detected using autosomal markers anymore. Due to
the lack of PCR competition it is still possible to find Y-STR signals (Roewer, 2009). This was
the case for most of the samples.
Looking at table 6, it can be seen that two samples, the vulvar (oral contact- no semen)
and the buccal: saliva (1:10) dilution had a sufficient amount of male DNA present but produced
only female STR results. Since the samples contained enough male DNA to be amplified, it was
the mixture ratio of greater than 1:20 that prevented the autosomal kit to detect some presence of
male even if at a low level. When the same samples were tested with Y-Filer, full Y-STR
profiles were generated. More extreme mixtures >1:100 still yielded partial Y-STR profiles.
Basically, for samples with a M:F ratio from 1:1 to 1:20, a male DNA profile can be generated
with the Globalfiler kit, M:F ratios between 1:20 and 1:100 generated low level male DNA
profiles using the Globalfiler kit, and no male DNA profiles were detected with M:F ratios from
1:500 to 1:1600. Y-STRs were detected and generated for all M:F ratios ranging from 1:1 to
1:1600. It is important to note, that these samples were Y-Screen positive. The combination of
Y-Screen and Y-STR will increase success rates in cases with male female mixtures.
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Table 6. Selected Y-Screen positive samples sorted by M:F ratios

Sa mpl e Type
peri a na l :s emen
(feca l ma teri a l )

Y-Screen Y-Screen
Regul a r
Regul a r
Huma n
Ma l e
Ext.
Y-Screen
Ext. Ma l e
Fra cti on
Ta rget
Ta rget M:F Ra ti o
Huma n
Qua nt
Qua nt
Qua nt
Qua nt
0.37219

0.45982

1:1.2

Regul a r
Ext.M:F
Ra ti o

Gl oba l Fi l er Res ul ts

Y-Fi l er
Res ul ts

SF

9.7921

4.784

1:2

SS ma l e

Ful l YSTR

bucca l :s emen(1:1k)

0.28667

0.00381

1:75

SF

0.00500

0.00200

1:2.5

Mi xture

Ful l Y-STR

72 Hr PC

3.83756

0.01273

1:301

SF

0.0196

0.0078

1:2.5

Mi xture

Ful l YSTR

bucca l :s a l i va nea t

0.71552

0.26079

1:2.7

s td

1.11000

0.22990

1:4.8

Mi xture

Ful l Y-STR

bucca l :s a l i va (1:2)

0.35140

0.11556

1:3

s td

2.11990

0.10340

1:20

Mi xture

Ful l Y-STR
Ful l Y-STR

bucca l :s emen(1:10)

0.67922

0.22166

4 Da ys PC
12.39898 0.00043
Vul va r (ora l conta ct 3.20742 0.06734
no s emen)

1:3

EF

7.13650

0.31620

1:23

Mi xture - l ow l evel
ma l e (2 a l l el es )

1:28630

SF

0.0555

0.0022

1:25

SS fema l e

No profi l e

1:48

s td

8.3812

0.224

1:37

SS Fema l e

Ful l YSTR

Mi xture - l ow l evel
ma l e

Ful l Y-STR

bucca l :s a l i va (1:10)

0.58146

0.01232

1:47

s td

3.90490

0.07390

1:53

48 Hr PC

6.01527

0.00188

1:3197.7

SF

0.06230

0.00100

1:63

Mi xture

3 l oci
9 l oci

bucca l :s emen (1:100) 0.41380

0.04686

1:7.8

bucca l :s a l i va (1:100) 0.50606

0.00056

1:903

a l penetra ti on (vul va r s 5.71221

EF

1.76900

0.01650

1:106

Pos s . mi xture - 1
ma l e pea k i n s tutter
pos i ti on

2.32080

0.00460

1:508

SS Fema l e

10 l oci

0.00654

1:872.6

39.94360

0.06810

1:585

SS Fema l e

15 l oci

72 Hr PC

3.83756

0.01273

1:301

EF

30.4826

0.0222

1:1373

SS fema l e

9 l oci

bucca l :s emen(1:1k)
Vul va r s wa b
(penetra ti on - no
s emen)

0.28667

0.00381

1:75

EF

1.99300

0.00140

1:1423

SS fema l e

1 l ocus

3.26419

0.00100

1:3257

s td

16.1251

0.01

1:1612

SS Fema l e

12 l oci

y-screen extract
Secondary extraction

DNA quantitation values are in ng/μL. This table is not a list of new samples but rather a
re-assortment.

In Table 7 we can see that, one condition for detecting Y- STR results is that the male
DNA component has sufficiently high quantitation results. Table 7 shows previously listed
samples where the Y-Screen had been positive, but no Y-STR results were obtained. All samples
had low amounts of DNA and were below the STR amplification cutoff value of 10pg/μL based
on the male Quantifiler Trio target.
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Table 7. Selected Y-Screen positive samples negative for Y-STRs

Sa mpl e Type

Y-Screen Y-Screen
Regul a r
Regul a r Regul a r
Huma n
Ma l e
Ext.
Y-Screen
Ext. Ma l e Ext.M:F
Fra cti on
Ta rget
Ta rget M:F Ra ti o
Huma n
Qua nt
Ra ti o
Qua nti ty Qua nt
Qua nt

bucca l :s emen
(1:100k)

0.04982

0.00014

1:357

SF

0.001

0.0002

1:3

bucca l :s emen
(1:10k)

0.53033

0.00029

1:1842

SF

0.00240

0.00030

1:7.5

12.39898 0.00043

1:28629

SF

0.0555

0.0022

1:25

SF

0.00730

0.00010

1:83

1.19570

0.00010

1:13411

4 Da ys PC
bucca l :s emen
(1:5k)
bucca l :s a l i va
(1:20k)

0.22386

0.00062

1:357

0.27120

0.00018

1:1482

y-screen extract
Secondary extraction

Gl oba l Fi l er Res ul ts

Y-Fi l er
Res ul ts

Pa rti a l fema l e - 3 l ow
No profi l e
l evel pea ks
Pos s Mi xture - 1 ma l e
pea k ca l l ed (not
No profi l e
s tutter pos i ti on)
SS fema l e
Mi xture - 2 l ow l evel
ma l e a l l el es
SS Fema l e

No profi l e
No profi l e
No profi l e

DNA quantitation values are in ng/μL. This table is not a list of new samples but rather a
re-assortment.

Table 8. Y-Screen negative results and STR typing outcome

Sample Type

5 Days pc
Oral (no male)

Y-Screen Y-Screen
Regular
Regular Regular
Human
Male
Ext.
Fraction
Ext. Male Ext.M:F
Target
Target
Human
Ratio
Quant
Quantity Quant
Quant
EF
40.267 0.0001 1:323801
7.8373 0.0000
SF
0.0353 0.0001 1:240
0.0269

Dried secretions (no male) 0.0243

0.0000

std

1.7605

GlobalFiler Results

Y-Filer
Results

SS female

No profile

SS female

No profile
No profile

0.0000

n/a

SS Female

0.0000

std

0.0886

0.0001

1:947

SS Female

No profile

Peri anal (no male)

0.0974

0.0000

std

0.0061

0.0000

n/a

SS Female

No profile

Vulvar (no male)

0.0162

0.0000

std

0.0792

0.0000

n/a

SS Female

No profile

vaginal (no male)

0.0232

0.0000

std

0.0347

0.0003

1:134

SS Female

No profile

buccal:saliva(1:1k)

0.1419

0.0000

std

0.7976

0.0010

1:831

SS Female

No profile

buccal:saliva(1:5k)

0.6368

0.0000

std

3.6653

0.0001

1:35065

SS Female

No profile

buccal:saliva(1:10k)

0.3842

0.0000

std

6.8773

0.0006

1:10644

SS Female

No profile

buccal:saliva(1:50k)

0.2429

0.0000

std

1.9378

0.0005

1:3574

buccal:semen(1:20k)

0.0814

0.0000

EF

0.3723

0.0000

SF

0.0004

0.0002

EF

4.8830

0.0002

SF

0.0049

0.0003

buccal:semen1:50k)

y-screen extract
Secondary extraction

0.1564

0.0000

SS Female
Poss Mixture - 1 male
n/a
peak called (in stutter
position)
Partial female - 3 low
1:1.3
level peaks
1:24415
SS female
Poss Mixture - 1 male
1:16
peak

No profile
No profile
No profile
No profile
No profile

DNA quantitation values are in ng/μL. This table is not a list of new samples but rather a
re-assortment.
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Table 8 again combines previously listed samples that were Y-Screen negative but still
extracted using either standard or differential extraction. Of the 12 samples that tested negative
for the presence of male DNA with the Y-Screen assay, none produced Y-STR profiles. These
results were concordant with the expectation, that if there is no male DNA present there should
be no Y-STRs detected. Autosomal typing detected the female contributor and generated mostly
single source female profiles. There were two exceptions: as can be seen in table 8, for the
buccal:semen (1:20K) sample the epithelial fraction (EF) which had a zero male value with the
Y-Screen and after differential extraction, had a possible male profile. It was determined that
there was one peak, which was not from the female called in a stutter position making the results
a possible mixture. This was unexpected due to the fact that, if there is no male DNA detected
with the Y-Screen assay or with the differential extraction, then no male DNA profile should
have been detected. For the (1:50K) sample, there was a single peak called in the sperm fraction
(SF), was considered a possible mixture, since the major component was the female profile. The
one peak that did not belong to the female profile was not located in a stutter position, but could
be allelic drop in. In both cases no Y-STR profile was generated and the single peak called in
Globalfiler STR typing may be deemed an artifact and not from the male contributor.

Reproducibility/ Repeatability
The repeatability/reproducibility study conducted for this validation had four mixture swabs of
1:1 mixtures of semen: saliva that were cut in triplicate and pooled to demonstrate the
reproducibility of the assay. The two analysts attempted to take similar sized cuttings
(approximately 1/8 of the swab) and performed the Y-Screen assay on different dates using
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different 7500 Real Time instruments. The results of the two sets of samples were compared and
appear in Table 9.

Table 9. Reproducibility/ Repeatability
Yscreen
Human
Instrument
Target
Quantity

Y-Screen
Male
Target
Quant

0.37461

0.31213

0.31156

0.35224

Semen:Saliva

0.33841

0.39066

Semen:Saliva

0.82756

0.74659

1.11761

1.04396

1.03629

0.91545

Sample Name

Analyst

Date

LS

1/12/2017

Semen:Saliva
Semen:Saliva

Semen:Saliva
Semen:Saliva

AD

1/20/2017

7500A

7500B

Mean YScreen
Male
Target
Quant

Std Dev.
Y-Screen
Male
Target
Quant

0.35168

0.03206

T- Test YScreen
Male
Target
Quant

0.003
0.902

0.12177

DNA quantitation values are in ng/μL. The t-test was conducted using pooled standard deviation values.

The results show that the assay is reproducible in detecting the presence of male DNA in
the sample. The assay also proves to be repeatable in that the analysts cutting from the same
sample obtained similar DNA concentrations. The reproducibility/repeatability study was done
to satisfy the FBI QAS criteria, if when the test is repeated the results are the same. While the
detection of male DNA was consistent, both analysts had different DNA concentration results.
To determine if there was a significant difference between the analysts carrying out the assay, a
T test was done based on the male real time values. The T test results stated that the samples had
a p-value of 0.003. Since the p-value is less than 0.05, it is concluded that there is a significant
difference between the two analysts. Since the study was used to verify if male DNA was
detected the difference between analysts sampling is not detrimental to the validation and the
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assay is still reproducible. The significant difference in concentration between the two sets is
attributed to sampling variation, or how much of the swab the analysts cut.
Contamination
Table 10. Extraction Negative controls

Sample Type

Yscreen
Human
Target
Quantity

Y-Screen
Male
Target
Quant

EN 1 011217

Extract negative

0.0000

0.0000

EN 2 011217

Extract negative

0.0000

0.0000

EN 3 012017

Extract negative

0.0000

0.0000

EN 4 012017

Extract negative

0.0000

0.0000

Sample Name

DNA quantitation values are in ng/μL.

Table 10, shows several extraction negatives that were run with each set of samples for
the Y-Screen assay, and demonstrates that no contamination occurred during the extraction.
There were no instances of contamination noted with the Y-Screen assay.

Additional Results
The samples shown in table 11 are different from those previously listed samples and
represent examples of Y-screens performed by the lab. This table focuses on the STR profiles
obtained from samples organized from the smallest Y-Screen value and up after either standard
or differential extraction. As can be seen values >0.1ng/μL in the Y-Screen consistently
generated CODIS eligible male autosomal profiles. Lower values need to be examined to
determine, if a cutoff using the Y-Screen male real time value can be used to decide what gets
chosen for further testing. Previously (see table 1) a value of below 0.0007 ng/μL was
considered predictive of negative STR results. Table 11 now shows one sample that had a YScreen male value of 0.0003ng/μL generating a CODIS profile. The secondary extraction uses a
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slightly bigger cutting and the result was a mixture in autosomal STR typing. This profile would
have been missed with a 6-10pg/µL cutoff. Therefore the cutoff value should be lower, only if
the real time Y-Screen value is zero, the sample should not be taken through to a secondary
extraction. This is also supported by two samples in table 5, where Y-Screen male target values
of 0.0010 and 0.0001 ng/µL produced Y-STR results.

Table 11. Samples sorted based on Male Y-Screen value
Y-Screen
Male
Target Y-Screen
Quant M:F Ratio
1:87
0.0001
1:23
0.0003

+
+

Type of
Extraction
Standard
Standard

Fraction

0.0017
0.0042
0.0046
0.0105
0.0132
0.0176

1:61
1:2
1:5
N/A
1:171
1:7.07

+
+
+
+
+
+

Standard
Standard
Standard
Standard
Differential
Differential

0.0301
0.1793
0.4393

1:214
1:8
N/A

+
+
-

Differential
Differential
Standard

SF
SF

0.6423
1.1997

N/A
1:5

+
+

Differential
Differential

SF
SF

2.5358
3.0726

1:1
1:6

+
+

Differential
Differential

SF
SF

y-screen extract
Secondary extraction

N/A
N/A
SF
EF

Regular
Regular Regular
Ext.
Human Ext. Male Ext.M:F DNA Profile CODIS
Quant
Quant
Ratio
Type
Eligible
mixture
1:46
0.1401
0.003
N
mixture
1:18
0.0023
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DNA quantitation values are in ng/μL.

Casework Results
The purpose of including an overview real casework results is to show that the Y-Screen
assay is a faster processing method for SAKs. After a year of having the Y-Screen assay
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implemented in the laboratory for use with casework, a total of 110 kits have been tested, a total
of 669 samples were run through the assay, and their subsequent STR results were obtained. The
average number of swabs tested per kit was six. Of these swabs 53% were positive for Y-Screen
and 47% were negative. After secondary extraction and autosomal STR testing, the number of
CODIS eligible profiles was higher for positive orifice swabs (58%) than body swabs (42%).
This may be due to the fact that the sample is more preserved in an orifice than, if it had been
deposited on the surface. A total of 130 swabs were taken all the way through to CE. From those
samples the majority of STR profiles that were developed were from the dried secretion swabs
and the vaginal swabs. Next were the perianal, anal and vulvar swabs. No eligible profiles were
developed from the oral or cervical swabs collected from the kits (see figure 1). Along with the
STR success there was some database success generated from the Y-Screen assay. 26 samples of
the 130 swabs taken through STR typing were eligible for CODIS and therefore entered into the
database. This is approximately 17% of all samples that were tested. From the 26 samples
entered, eight samples had state offender hits, meaning the profile entered matched a profile from
a convicted offender already in the database. This is a 30% hit rate.
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Figure 1. Percent of Swabs eligible for CODIS. The figure shows a pie chart of the types of
swabs with CODIS eligible male DNA profiles.

Discussion
All internal validations conducted by an accredited lab, must follow the FBI guidelines.
The guidelines provide criteria that must be met in each of the studies conducted. For an internal
validation, it is required to have a known and non-probative study, a reproducibility and
precision study, a sensitivity study, a mixture study and a contamination study. The internal
validation of the Y-Screen conducted at the Westchester County Forensic Laboratory, met all of
these requirements in order to implement the assay in casework. For the sensitivity study, it was
required that low quality and quantity samples be evaluated. For the known/mock study, it is
required that known samples with known contributors be used to test the ability of the assay. For
the reproducibility/repeatability study, it was required that the lab obtain the same results when
the test is repeated. For the mixture study, it was required that mixture samples be used to
establish guidelines for mixture interpretations. For the contamination study, it is required that
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the lab test samples to ensure no exogenous DNA is introduced into the samples during
processing.
Sensitivity
The Y-Screen assay will be a very useful screening tool to be used on swabs from sexual
assault kits for the detection of male DNA. It is more sensitive than conventional screening tests
for semen and will detect non-semen male DNA as well. The sensitivity study was conducted to
determine the limits or at how low male DNA, the Y-Screen assay could obtain a STR profile.
There were two sets of dilution mixtures generated to test these limits, the first being semen
dilutions and the second being saliva. The two sets were used in order to test the limits of the YScreen not only with semen DNA but other types of male DNA that could be present in real
swabs. The Y-Screen assay was able to detect male DNA in samples that were negative with
conventional AP and PSA screening tests; it can detect male DNA in the form of saliva or touch,
which would be missed with the presumptive AP test, since the AP tests for a semen specific
enzyme. The Y-Screen can detect male DNA in semen dilutions down to 10,000x. Samples that
gave negative results for AP and PSA, still provided Y-STR profiles. For the male saliva dilution
set, the Y-Screen was able to detect saliva down to a 1:100 dilution. The Y-Screen assay is able
to detect the presence of male DNA down to a lower concentration since it utilizes PCR
amplification and targets DNA rather than a protein as in the case of AP and PSA. It proved to be
sensitive with dilutions of male semen and saliva, as well as detect male DNA on post coital
swabs.
Known/Mock
The QAS requires that an internal validation have a known and mock sample study (FBI,
2011). The validation provided known samples with known contributors to test the ability of the
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assay. The known mock samples were a combination of semen male DNA and saliva/touch
DNA, including negative samples. The results determined that all positive Y-Screen samples
yielded STR profiles concordant with the known contributors. All negative samples were
negative for the Y-Screen.
Reproducibility/ Repeatability
The Y-Screen also proved to be reproducible among different cuttings of the same
sample and different analysts sampling the same sample. The results show that the assay is
reproducible in detecting the presence of male DNA in the sample when the analyst takes
multiple cuttings from the same sample. The assay has also been shown to be reproducible across
different instruments on different days, as well as across different analysts.
Mixture
The criteria that is implemented by the FBI QAS is that mixed DNA samples should be
used to represent those typically encounter by the testing laboratories, to establish guidelines for
mixture interpretations (FBI, 2011). The samples that were generated for this study were a
mixture of female and male DNA. These samples were used to mimic swabs typically
encountered in sexual assault kits. The Quantifiler Trio software produces a male to female ratio
for samples that contain mixtures of male to female DNA. The results from these samples
support that as the ratio of female DNA increases relative to male DNA, the ability to detect the
minor male component may be limited with autosomal STR analysis and compared to the Y-STR
analysis.
Contamination
The contamination study criteria set by the QAS, is that the samples are run through the
assay to test for the unintentional introduction of exogenous DNA into a DNA sample or PCR
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reaction (FBI, 2011). To ensure no exogenous DNA was coming into contact with the samples
during the extraction with the Y-Screen assay, an extraction negative with a blank swab was run
alongside for each batch of extractions. The expected results were to see no presence of DNA.
The four extraction negatives evaluated had no human or male DNA detected using the
Quantifiler Trio kit.
Casework Impact
The Y-Screen result was shown to have a correlation with the autosomal and Y-STR
results. The swabs that are positive with the Y-Screen assay for the presence of male DNA, are
pushed forward meaning they get extracted a second time and go through the whole DNA
process of amplification to STR typing. The Y-Screen assay determines which sample has male
DNA, but the quality of the STR profile is based on the secondary extraction of that sample. The
correlation to the Y-Screen assay is more of an indication of what should be expected. If there is
a high quantitative value of male DNA present, it can be expected that the sample will provide a
full Y-STR profile. If the sample had a low quantitative value of male DNA then it is expected to
see mixtures in STR typing. In the case were a low quantitative value of male DNA is detected,
there may be a single source female profile detected, if the female DNA overpowers the male
component in the mixture.
This assay will affect current practices on the processing of sexual assault kits by cutting
down on the cost, number of samples extracted for DNA, and improving downstream sample
processing. Only positive Y-Screen assay samples need to be put through for the second
extraction and it is possible to select the most promising (highest Y screen value) for the kit. This
will improve turnover time and reduce backlog. When compared to casework processing using
the old workflow, 82 SAK kits were received and of those kits received only 67 were processed
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in a year. Of those 82 kits received a total of 472 swabs were tested for AP/PSA; approximately
354 swabs had to be taken through to CE. Using the Y-Screen assay the laboratory was able to
process 110 kits in one year with a total of 130 samples take through to CE. This reduction was
due to only one swab getting extracted. Figure 2 shows the previous SAK workflow.
Prior to the use of the Y-Screen assay, the processing of swabs from a SAK was very
time consuming demonstrated by the flowchart. The way the samples were processed is as
follows; a cutting of the swab was take and tested with the AP reagents, this takes approximately
five minutes. Then another sample of that same swab is cut and placed in a tube to be tested for
PSA at a later date. In most labs, samples are batched in groups. The samples that were cut for
PSA testing are batched and soaked once a week, meaning if you did not have them cut for the
testing date that week you would have to wait an additional week before the samples get tested.
In the testing phase the samples take approximately 3 hours to obtain PSA results. Therefore it
can take a whole week from when the analyst itemizes the SAK, to when the samples are
incubated and tested with PSA. From there if the samples are PSA positive, they get sent onward
for differential DNA extraction which is also batched once a week, meaning that if the sample is
not cut in time for the following week, the sample would not get incubated for an additional
week. If the sample is negative for PSA, an extract slide is made and the original slide collected
with the kit would be stained and read. It takes approximately an hour and a half to stain the
extract slide and an hour to stain the original slide. The stained slide must then be read; this
could be the same day or any day. Depending on the results, the slide would determine if the
sample was sent to DNA extraction. Therefore it can take anywhere from two to four weeks to
process samples from one SAK. The Y-Screen assay takes 30-45 minutes to extract the sample.
Then it would get placed on the 7500 Real time either that day or the next and the analyst can
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have the results of which samples to take through to extraction within one week of itemization of
the kit.

Figure 2. SAK Workflow prior to Y-Screen Assay. This workflow was followed in the
processing of SAK’s prior to the Y-Screen assay. It shows how the processing was more
serological dependent and how the samples were sent downstream for extraction.
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Figure 3 is the flowchart of how the Y-Screen assay is used to processes SAK’s.

Figure 3 SAK flowchart after implementation of the Y-Screen assay. It shows the downstream
decision making based on the presences or absence of male DNA. Unlike the old work flow if
no male DNA is detected the analysis ends there and no slides have to be stained or read.

It is clear to see from the flow chart that the Y-Screen assay provides for a more
streamlined process. To extract a sample takes approximately half an hour. This will reduce the
amount of time and cost it takes to process the kit with the elimination of AP/PSA testing. The
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slide staining and reading is performed only for swabs that are candidates for
differential/standard extraction. The time taken for reading the slide has been shortened by
having a scan of the slide submitted from the Y-Screen assay and then reviewed. A full scan is
conducted in ten minutes. If no spermatozoa are detected in that time, the slide is recorded as
being negative. The slide results determine, if a differential extraction or non-differential
(standard) robotic extraction is to be conducted on the swab. Negative slide results indicate a
non-differential extraction and a positive spermatozoa slide means the sample needs differential
extraction. The Y-Screen implementation data shows its success in generating CODIS profiles;
this addresses the high throughput needs of forensic laboratories. The casework implementation
shows the success of the Y-Screen assay in improving the turnaround time. Of the 110 cases run
through this assay in a year, every single deadline was met, be it an old or new case for the 3month due date.
Limitations
The Y-Screen assay was predictive of the downstream results. A positive male Y-Screen
quantification result correlated with a positive male quantification result post extraction. The
assay was proven useful with mixtures as well. A low quantification result with the Y-Screen
generally correlated to low quantification results post extraction. The manufacturer has
emphasized limitations to this correlation due to the fact that there have been some cases seen,
where a sample had a Y-Screen value below the amplification threshold that when taken through
to CE actually generated a Y-STR profile (ThermoFisher Scientific, 2015). This was also
observed in this validation.
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The assay can only be used on swabs due to it being a crude lysis extraction and
inhibitors might be present that may impact the IPC (internal positive control) and the
degradation marker results. In the Y-Screen assay this is a limitation. In this study the Real Time
PCR, showed elevated out of range values for the internal PCR control (IPC) for several
samples. The samples that had this elevated IPC were negative for male/human DNA and
normally run the same day they were extracted. When the samples were requantified later their
IPC values were in range with the parameters for the lab. It was unclear as to why the samples
worked the second time. The theory was tested with fresh sodium hydroxide made in smaller
batches and more frequently. When the issue continued to occur, it was believed that the
inhibition may be caused by the glacial acetic acid that is added during the lysate.
To study this issue further, a test was conducted alongside a Y-Screen assay extraction,
by adding a sample of neat glacial acetic acid to the Quantifiler Trio quantitated batch. All
samples for this run worked with no problems with the IPC’s except for the straight glacial acetic
acid, which had caused inhibition. It was concluded that a way to remove this problem was to
vortex the samples after the addition of glacial acetic acid. It was found that there was no
inhibition for the samples when the samples were vortexed.
Advantages/Disadvantages
With any new method or technique, it has its advantages and disadvantages. The YScreen assay has several advantages. The first advantage of the implementation of the assay is
that it improves the overall turnaround time in the processing of SAK’s. The assay allows analyst
to extract 1-2 samples instead of consuming swabs and time to test for AP and PSA and reading
all the slides in the kit, which means the Y-Screen is quicker in pinpointing which swabs have
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male DNA present. This is also more cost efficient. Another advantage of the assay is its ability
to detect the presence of male DNA, even in minute amounts not only for semen but saliva and
touch sources. SAK’s previous testing was based on serological tests (AP and PSA). These tests
were shown to not be as sensitive or reliable as using Y-Screen to detect male DNA in samples.
The assay only uses a small cutting, then a slightly larger cutting for the secondary extraction,
which prevents the consumption of the whole sample.
There are some disadvantages with the assay. One disadvantage is that the assay is so
sensitive it detects low male values; these low values sometimes do not yield a male STR profile.
This could be instrument noise or the male DNA is too low to produce a male STR profile.
Another disadvantage is that the first cutting which gets extracted with the Y-Screen cannot be
used for amplification, since it is a crude lysis extraction and with no purification the inhibitors
are still present. Samples always have to be extracted twice to be taken through to STR typing.
Conclusion
The Y-Screen assay has proven to be a useful tool in the processing of SAK’s. The assay
has shown to be more sensitive than the conventional AP/PSA testing in generating Y-STR
profiles. The Y-Screen assay not only detects male DNA in semen but rather any type of male
DNA (saliva and touch). From all the mock samples that have been run through this assay, there
were no false negatives observed, meaning if there was no Y-Screen male Real Time value, no
STR result was obtained. If male DNA was detected with the assay, the STR success depended
on the Y-Screen value. Y-Screen values greater than 10 pg/μL always had some type of male
signal detected after the second extraction. Below that 10 pg/μL value, some samples yielded YSTR profiles, but others were negative. The Y-Screen assay has demonstrated a sufficient
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correlation between the first extraction results with downstream STR results, and is an
appropriate tool to help solve the rape kit backlog issue.
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